Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

被引：0
|
作者：
Ralf W. Dittmann
Esther Cardo
Peter Nagy
Colleen S. Anderson
Ralph Bloomfield
Beatriz Caballero
Nicholas Higgins
Paul Hodgkins
Andrew Lyne
Richard Civil
David Coghill
机构：
[1] University of Heidelberg,Paediatric Psychopharmacology, Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim
[2] University of the Balearic Islands,Son Llàtzer Hospital and Research Institute on Health Sciences
[3] Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic,Division of Neuroscience
[4] Shire Development LLC,undefined
[5] Shire Pharmaceutical Development Ltd,undefined
[6] Shire AG,undefined
[7] University of Dundee,undefined
来源：
CNS Drugs | 2013年 / 27卷
关键词：
Atomoxetine; Guanfacine; ADHD Medication; Lisdexamfetamine; Amfetamine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1081 / 1092
页数：11
相关论文
共 50 条
  • [31] Long-term safety of lisdexamfetamine dimesylate (LDX) in adolescents with attention-deficit/hyperactivity disorder
    Findling, R.
    Childress, A.
    Cutler, A.
    Hamdani, M.
    Ferreira-Cornwell, M. C.
    Shaw, M.
    Gasior, M.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2011, 20 (01) : S117 - S118
  • [32] The Efficacy and Safety Profile of Lisdexamfetamine Dimesylate, a Prodrug of d-Amphetamine, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adults
    Najib, Jadwiga
    CLINICAL THERAPEUTICS, 2009, 31 (01) : 142 - 176
  • [33] Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
    Weisler, Richard
    Young, Joel
    Mattingly, Greg
    Gao, Joseph
    Squires, Liza
    Adler, Lenard
    CNS SPECTRUMS, 2009, 14 (10) : 573 - 585
  • [34] Phase II/III Study of Lisdexamfetamine Dimesylate in Japanese Pediatric Patients with Attention-Deficit/Hyperactivity Disorder
    Ichikawa, Hironobu
    Miyajima, Tasuku
    Yamashita, Yushiro
    Fujiwara, Masakazu
    Fukushi, Akimasa
    Saito, Kazuhiko
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (01) : 21 - 31
  • [35] Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study
    Jafarinia, Morteza
    Mohammadi, Mohammad-Reza
    Modabbernia, Amirhossein
    Ashrafi, Mandana
    Khajavi, Danial
    Tabrizi, Mina
    Yadegari, Noorollah
    Akhondzadeh, Shahin
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2012, 27 (04) : 411 - 418
  • [36] A randomized, double-blind study of continuation treatment for attention-deficit hyperactivity disorder after 1 year
    Buitelaar, Jan K.
    Michelson, David
    Danckaerts, Marina
    Gillberg, Christopher
    Spencer, Thomas J.
    Zuddas, Alessandro
    Faries, Douglas E.
    Zhang, Shuyu
    Biederman, Joseph
    BIOLOGICAL PSYCHIATRY, 2007, 61 (05) : 694 - 699
  • [37] Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial
    Coghill, David R.
    Banaschewski, Tobias
    Lecendreux, Michel
    Soutullo, Cesar
    Zuddas, Alessandro
    Adeyi, Ben
    Sorooshian, Shaw
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 2039 - 2047
  • [38] Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Effects of Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts on Cognition Throughout the Day in Adults with Attention-Deficit/Hyperactivity Disorder
    Martin, Patrick T.
    Corcoran, Mary
    Zhang, Pinggao
    Katic, Alain
    CLINICAL DRUG INVESTIGATION, 2014, 34 (02) : 147 - 157
  • [39] Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Effects of Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts on Cognition Throughout the Day in Adults with Attention-Deficit/Hyperactivity Disorder
    Patrick T. Martin
    Mary Corcoran
    Pinggao Zhang
    Alain Katic
    Clinical Drug Investigation, 2014, 34 : 147 - 157
  • [40] Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder
    Gordon, Chanelle T.
    Fabiano, Gregory A.
    Hulme, Kevin F.
    Sodano, Sandro M.
    Adragna, Michael
    Lim, Rachel
    Stanford, Samantha
    Janikowski, Leah
    Bufalo, Bradley
    Rodriguez, Zulema
    Swiatek, Denise
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2021, 29 (04) : 308 - 318
12345